97 related articles for article (PubMed ID: 11823724)
1. Type 2 diabetes management.
Nelson G
Br J Community Nurs; 2002 Jan; 7(1):5. PubMed ID: 11823724
[No Abstract] [Full Text] [Related]
2. Treating type 2 diabetes. When diet and exercise aren't enough, a broad range of medications can help control our blood sugar.
Blackburn GL
Health News; 2004 Aug; 10(8):4-5. PubMed ID: 15551454
[No Abstract] [Full Text] [Related]
3. [Type 2 diabetes. Regulating insulin according to need].
MMW Fortschr Med; 2001 Oct; 143(42):62. PubMed ID: 11697294
[No Abstract] [Full Text] [Related]
4. [Metformin--its regimen and effects].
Shiba T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():382-8. PubMed ID: 12387022
[No Abstract] [Full Text] [Related]
5. [Glinides and glitazones in diabetes treatment. Are they really effective?].
Parhofer KG; Göke B
MMW Fortschr Med; 2002 May; 144(18):34-6, 38-9. PubMed ID: 12422705
[TBL] [Abstract][Full Text] [Related]
6. [Dangerous postprandial glucose peaks. Risk for heart and blood vessels].
MMW Fortschr Med; 2002 May; 144(21):58. PubMed ID: 12134432
[No Abstract] [Full Text] [Related]
7. [symbol: see text] Nateglinide and [symbol: see text] repaglinide for type 2 diabetes?
Drug Ther Bull; 2003 Jul; 41(7):52-4. PubMed ID: 12879789
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of type 2 diabetes. Effective control of postprandial glucose surges].
MMW Fortschr Med; 2001 Jul; 143(28-29):56-7. PubMed ID: 11499153
[No Abstract] [Full Text] [Related]
9. Nateglinide versus repaglinide for type 2 diabetes mellitus in China.
Li C; Xia J; Zhang G; Wang S; Wang L
Acta Diabetol; 2009 Dec; 46(4):325-33. PubMed ID: 19183841
[TBL] [Abstract][Full Text] [Related]
10. [Clinical trial of AY4166].
Kikuchi M
Nihon Rinsho; 1997 Nov; 55 Suppl():164-70. PubMed ID: 9434462
[No Abstract] [Full Text] [Related]
11. Drugs for type 2 diabetes.
Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949
[No Abstract] [Full Text] [Related]
12. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
Raskin P
Diabetes Obes Metab; 2008 Dec; 10(12):1167-77. PubMed ID: 18494804
[TBL] [Abstract][Full Text] [Related]
13. [Islands cells are not activated quickly enough. Risk of obstruction of blood vessels].
MMW Fortschr Med; 2002 Jun; 144(26):55. PubMed ID: 12154484
[No Abstract] [Full Text] [Related]
14. Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment-naïve patients with type 2 diabetes.
Horton ES; Foley JE; Shen SG; Baron MA
Curr Med Res Opin; 2004 Jun; 20(6):883-9. PubMed ID: 15200747
[TBL] [Abstract][Full Text] [Related]
15. Postprandial lipid profile in patients with type 2 diabetes.
Katsiki N; Kolovou G
Curr Med Res Opin; 2014 Jan; 30(1):121. PubMed ID: 24024786
[No Abstract] [Full Text] [Related]
16. [Prandial glucose regulator and insulin secretagogue; glinide and its combination therapy].
Nakashima E
Nihon Rinsho; 2015 Mar; 73(3):416-23. PubMed ID: 25812367
[TBL] [Abstract][Full Text] [Related]
17. Preventing the progressive nature of type 2 diabetes.
Cardiovasc J S Afr; 2002; 13(4):211-3. PubMed ID: 12402899
[No Abstract] [Full Text] [Related]
18. For diabetes: a preprandial pill ..
Health News; 1998 Jul; 4(9):5. PubMed ID: 9693447
[No Abstract] [Full Text] [Related]
19. Comments on type 2 diabetes screening and treatment.
Kolaczynski JW
Am Fam Physician; 2000 Jan; 61(1):49-50. PubMed ID: 10643950
[No Abstract] [Full Text] [Related]
20. Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide.
Scheen AJ
Clin Pharmacokinet; 2007; 46(2):93-108. PubMed ID: 17253883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
